Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Oncology Reports|February 19, 2005
Novel kinase inhibitors in renal cell carcinoma: progressive development of static agentsApurva A Desai, Walter M Stadler
Current Urology Reports|February 17, 2006
Novel kinase inhibitors in renal cell carcinoma: progressive development of static agentsApurva A Desai, Walter M Stadler
Pharmacogenetics|August 2, 2003
UGT pharmacogenomics: implications for cancer risk and cancer therapeuticsApurva A Desai, Federico Innocenti, Mark J Ratain
Oncogene|October 7, 2003
Pharmacogenomics: road to anticancer therapeutics nirvana?Apurva A Desai, Federico Innocenti, Mark J Ratain
Pharmacogenetics and Genomics|May 3, 2005
Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genesFederico Innocenti, Wanqing Liu, Peixian Chen, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2020
A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumorsTracy Murray Stewart, Apurva A Desai, Michael L Fitzgerald, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2006
Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancerMichael L Maitland, Rebecca Wilcox, D Kyle Hogarth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2007
Lack of association between common polymorphisms in UGT1A9 and gene expression and activityJacqueline Ramírez, Wanqing Liu, Snezana Mirkov, et al.
Pageof 3